| Type 2 Diabetes Mellitus |
1 |
1 |
| Biomarker |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.68 |
| Heart Failure (HF) |
0 |
0.49 |
| Cardiometabolic Risk Factors |
0 |
0.38 |
| Coronary Heart Disease Risk Factors |
0 |
0.31 |
| Coronary Artery Disease (CAD) |
0 |
0.3 |
| Healthcare and Medical Technology |
0 |
0.22 |
| Clinical Research |
0 |
0.21 |
| Heart |
0 |
0.21 |
| California |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.14 |
| SGLT2 Inhibitor |
0 |
0.14 |
| Cerebrovascular Accident |
0 |
0.13 |
| Thromboembolism |
0 |
0.1 |
| B-Type Natriuretic Peptide |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Deep Venous Thrombosis |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Ischemic Stroke |
0 |
0.07 |
| Myocardial Infarction (MI) |
0 |
0.07 |
| Pulmonary Embolism |
0 |
0.07 |
| Troponin |
0 |
0.07 |